Sigma Planning Corp Age X Therapeutics, Inc. Transaction History

Sigma Planning Corp

$3.22 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$0.33 - $0.74 $34,663 - $77,729	105,040 Added 57.91%	286,425 $108,000
Q3 2023 Nov 06, 2023	BUY	$0.67 - $0.85 $27,928 - $35,432	41,685 Added 29.84%	181,385 $123,000
Q2 2023 Aug 01, 2023	BUY	$0.45 - $0.89 $3,825 - $7,565	8,500 Added 6.48%	139,700 $124,000
Q1 2023 May 05, 2023	SELL	$0.56 - $0.8 $2,115 - $3,021	-3,777 Reduced 2.8%	131,200 $86,000
Q4 2022 Jan 24, 2023	BUY	$0.54 - $0.68 $9,599 - $12,088	17,777 Added 15.17%	134,977 $0
Q3 2022 Nov 10, 2022	BUY	$0.55 - $0.74 $302 - $407	550 Added 0.47%	117,200 $66,000
Q2 2022 Aug 11, 2022	BUY	$0.57 - $1.0 $16,530 - $29,000	29,000 Added 33.09%	116,650 $67,000
Q1 2022 Apr 20, 2022	SELL	$0.65 - $1.2 $357 - $660	-550 Reduced 0.62%	87,650 $75,000
Q3 2021 Oct 28, 2021	BUY	$0.93 - $1.54 $33,945 - $56,210	36,500 Added 70.6%	88,200 $83,000
Q2 2021 Aug 13, 2021	BUY	$1.14 - $1.77 $32,147 - $49,914	28,200 Added 120.0%	51,700 $80,000
Q1 2021 May 06, 2021	BUY	$1.56 - $2.7 $5,148 - $8,910	3,300 Added 16.34%	23,500 $38,000
Q4 2020 Feb 09, 2021	BUY	$0.8 - $2.56 $2,824 - $9,036	3,530 Added 21.18%	20,200 $31,000
Q3 2020 Nov 03, 2020	BUY	$0.79 - $1.52 $1,580 - $3,040	2,000 Added 13.63%	16,670 $14,000
Q2 2020 Jul 31, 2020	SELL	$0.68 - $1.13 $673 - $1,118	-990 Reduced 6.32%	14,670 $14,000
Q1 2020 May 01, 2020	SELL	$0.78 - $1.95 $18,010 - $45,025	-23,090 Reduced 59.59%	15,660 $15,000
Q4 2019 Feb 03, 2020	SELL	$1.25 - $1.82 $2,240 - $3,261	-1,792 Reduced 4.42%	38,750 $71,000
Q3 2019 Nov 01, 2019	SELL	$1.96 - $3.38 $3,800 - $6,553	-1,939 Reduced 4.56%	40,542 $79,000
Q2 2019 Aug 01, 2019	BUY	$2.58 - $4.92 $21,210 - $40,447	8,221 Added 24.0%	42,481 $156,000
Q1 2019 May 01, 2019	BUY	$3.0 - $4.85 $102,780 - $166,161	34,260 New	34,260 $139,000

Others Institutions Holding AGE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Corsicana & Co.

1K
Shares

$0
0.0% of portfolio

View Full List

About AgeX Therapeutics, Inc.

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

More about AGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Account